May 22nd 2025
Jared S. Winoker, MD, addresses the wide range of stone burdens treated by the CVAC system for the study.
May 21st 2025
The application is seeking an expanded indication of talazoparib plus enzalutamide for mCRPC.
The committee voted 4-5 in opposition of a favorable benefit-risk profile.
May 20th 2025
Results from the phase 3 AMPLIFY trial are intended to support an application to the FDA for potential approval of 64Cu-SAR-bisPSMA.
The phase 3 study design will now be submitted for final review by the agency.
Study shows value of precision-based approaches in prostate cancer
The study found differences in genomic alteration frequencies between non-Hispanic Black and non-Hispanic White veterans with metastatic prostate cancer, but showed similar survival outcomes.
Urologic surgeons successfully complete world’s first bladder transplant
The bladder transplant procedure involved a collaboration between the University of California, Los Angeles and the University of Southern California.
Patient selection for cytoreductive nephrectomy in 2025
"Appropriate patient selection for CN is a highly individualized process that is improved with a multidisciplinary approach," write the authors.
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
Explore the latest insights on testosterone therapy, its benefits, and practical applications from leading urologists in men's health.
SBRT may offer a safe alternative to CFRT after prostatectomy
Data from the SCIMITAR trial showed that SBRT appeared safe and demonstrated comparable PROs compared with CFRT.
Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI
The CELLEBRATE trial is aiming to provide additional evidence to support the safety and efficacy of iltamiocel.
Real-time IRP monitoring may redefine safety and scope of flexible ureteroscopy
Professor Andreas Skolarikos shares his experience with the LithoVue Elite System.
Telehealth in urologic cancer: Lessons learned from the COVID-19 pandemic
"The use of telemedicine is heavily dependent on supportive legislature," write Tracey L. Krupski, MD, and Jeunice Owens-Walton, MD.
Published data support safety, efficacy of vaginal insert for SUI
Yōni.Fit bladder support was granted FDA 510(k) clearance in May 2024.
Enrollment progresses in study for cisplatin-induced hearing loss in testicular cancer
ACOU085 will be administered in 1 ear, with a matching placebo injection in the respective contralateral middle ear.
Long-term data point to durable efficacy of Optilume for urethral strictures
The freedom from re-intervention rate was 71%.
MRI and focal therapy may enable men on AS to safely delay surgery or radiation
Use of focal therapy was shown to prolong the duration of active surveillance.
National Women’s Health Week: Celebrating women shaping the future of urology
"I’m hopeful because women in urology are no longer an exception—they’re becoming the norm," says Shaya Taghechian, MD.
Disitamab vedotin plus toripalimab extends PFS, OS in HER2-positive la/mUC
The phase 3 RC48-C016 trial met its primary end points.
We got a little MIST-y at this year’s AUA Annual Meeting
Urologist Garrett D. Pohlman, MD, reflects on the benign prostatic hyperplasia offerings from the 2025 American Urological Association Annual Meeting.
Durvalumab plus BCG significantly improves DFS in NMIBC
The data are to be presented at an upcoming medical conference.
Artificial urinary sphincter for SUI shows safety, efficacy in prospective study
"This trial will be the benchmark for research reporting in the future," says Melissa R. Kaufman, MD, PhD, FACS.
Stent omission after ureteroscopy is safe, improves patient-reported outcomes
Patient-reported pain scores were significantly improved with stent omission.
Intervention to increase fluid intake does not reduce recurrent stones
“We do not feel that our results undermine the importance of fluid intake for stone prevention," says Alana C. Desai, MD.
Physical function and frailty measures offer distinct insights in patients with bladder cancer
Data showed that physical function and self-reported frailty assessments were poorly correlated.
FDA to host advisory committee meeting on UGN-102 for NMIBC
The Oncologic Drugs Advisory Committee meeting is scheduled for May 21, 2025.
Phase 2 trial launches of (177Lu) rhPSMA-10.1 injection in mCRPC
Initial study results may be available as soon as the first half of 2026.
AUA Advocacy Summit: Medicare payment reform among top priorities
Jennifer Miles-Thomas, MD, URPS, MBA, discusses the AUA's legislative priorities along with issues in medicine related to artificial intelligence.
AUA 2025 recap: Urologic oncology trials in progress
Take a look through some of the notable studies that were spotlighted during this year’s meeting.
FDA issues refusal to file letter on sBLA for nogapendekin alfa inbakicept
The sBLA for NAI was submitted to the FDA in March 2025.